This led to the development of ProstaScint® for PCa imaging using radiolabelled 7E11-C5,20 and although this was a significant breakthrough in the field it was later discovered that this antibody only detected binding to intracellular PSMA of necrotic cells. Here, FOLH1 is linked to posterior cortical atrophy.